v3.8.0.1

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Current assets
Cash	$ 56,363	$ 3,507
Accounts receivable, net	104,796	140,000
Other current assets	35,011	1,139
Total current assets	196,170	144,646
Property and equipment, net	32,915	25,545
Intangible assets, net
TOTAL ASSETS	229,085	170,191
Current liabilities
Bank overdraft		51,290
Accounts payable	131,188	157,490
Accrued liabilities	22,671
Accrued compensation	160,500	75,000
Payroll liabilities	29,606	21,406
Other payables	127,286	167,411
Due to related party	17,330	17,330
Convertible notes, net of debt discount of $259,357	69,143
Derivative liability	496,965
Total current liabilities	1,054,689	489,927
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock: authorized 100,000,000 shares, $0.001 par, 1,500,000 and 0 issued and outstanding	1,500
Common stock: authorized 500,000,000 common shares, $0.001 par, 49,139,998 and 344,139,998 issued and outstanding	49,140	344,140
Additional paid-in capital	7,246,439	6,952,939
Accumulated deficit	(8,122,683)	(7,616,815)
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	(825,604)	(319,736)
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)	$ 229,085	$ 170,191

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

PROTO SCRIPT PHARMACEUTICAL CORP 10-Q